Kaempferol-loaded nanoparticles were fabricated and evaluated in a hepatocellular carcinoma model, offering a suitable delivery system for kaempferol during hepatic cancer and Nrf2 signal modulation [94]. The gene discussed is NFE2L2; the disease is hepatocellular carcinoma.